UA30143C2 - TREATMENT FOR PREVENTION AND TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES - Google Patents

TREATMENT FOR PREVENTION AND TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES

Info

Publication number
UA30143C2
UA30143C2 UA97126437A UA97126437A UA30143C2 UA 30143 C2 UA30143 C2 UA 30143C2 UA 97126437 A UA97126437 A UA 97126437A UA 97126437 A UA97126437 A UA 97126437A UA 30143 C2 UA30143 C2 UA 30143C2
Authority
UA
Ukraine
Prior art keywords
treatment
infectious
prevention
inflammatory diseases
pharmaceutical diluent
Prior art date
Application number
UA97126437A
Other languages
Ukrainian (uk)
Other versions
UA30143A (en
Inventor
Юрій Семенович Кривошеін
Адоліна Петрівна Рудько
Original Assignee
Юрій Семенович Кривошеін
Адоліна Петрівна Рудько
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59701562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA30143(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Юрій Семенович Кривошеін, Адоліна Петрівна Рудько filed Critical Юрій Семенович Кривошеін
Priority to UA97126437A priority Critical patent/UA30143C2/en
Publication of UA30143A publication Critical patent/UA30143A/en
Publication of UA30143C2 publication Critical patent/UA30143C2/en

Links

Abstract

Лікувальний препарат для лікування та профілактики інфекційних та запальних захворювань, який містить ефективну кількість активної речовини ( 0,01 - 1,0 % ), якою є бензилдиметил[3-(міростиїламіно)пропіл]амонію хлорид та фармацевтичний розріджувач. Як фармацевтичний розріджувач може бути використана будь-яка фармацевтично прийнятна рослинна, тваринна або синтетична основа.A medicament for the treatment and prevention of infectious and inflammatory diseases, containing an effective amount of the active substance (0.01 - 1.0%), which is benzyldimethyl [3- (myrostylamino) propyl] ammonium chloride and a pharmaceutical diluent. Any pharmaceutically acceptable vegetable, animal or synthetic base may be used as a pharmaceutical diluent.

UA97126437A 1997-12-30 1997-12-30 TREATMENT FOR PREVENTION AND TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES UA30143C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA97126437A UA30143C2 (en) 1997-12-30 1997-12-30 TREATMENT FOR PREVENTION AND TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA97126437A UA30143C2 (en) 1997-12-30 1997-12-30 TREATMENT FOR PREVENTION AND TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES

Publications (2)

Publication Number Publication Date
UA30143A UA30143A (en) 2000-11-15
UA30143C2 true UA30143C2 (en) 2001-11-15

Family

ID=59701562

Family Applications (1)

Application Number Title Priority Date Filing Date
UA97126437A UA30143C2 (en) 1997-12-30 1997-12-30 TREATMENT FOR PREVENTION AND TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES

Country Status (1)

Country Link
UA (1) UA30143C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4411C1 (en) * 2010-02-19 2016-11-30 Megainpharm Gmbh Pharmaceutical including benzyldimethyl(3-[myristoylamino]propyl)-ammonium chloride and its use for the treatment and prevention of infectious and pyoinflammatory diseases of different etiology and localization

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4411C1 (en) * 2010-02-19 2016-11-30 Megainpharm Gmbh Pharmaceutical including benzyldimethyl(3-[myristoylamino]propyl)-ammonium chloride and its use for the treatment and prevention of infectious and pyoinflammatory diseases of different etiology and localization

Also Published As

Publication number Publication date
UA30143A (en) 2000-11-15

Similar Documents

Publication Publication Date Title
PT750618E (en) OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
NO950297L (en) Prolinamidderivater
DE69736441D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISEASES
ZA919317B (en) Novel hydroxamic acid and N-hydroxyurea derivatives and their use.
AU7405387A (en) Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
HUP0203590A2 (en) Remedies for diseases in association with decrease in bone mass
NO951498D0 (en) Pharmaceutical preparation for the treatment of osteoporosis
PT902789E (en) ANDROSTENE DERIVATIVES
RU93032613A (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PATIENTS WITH PROLONGED COAGULATION TIME, METHOD OF TREATING PATIENTS, USING THE EPI INHIBITOR FOR OBTAINING THE PHARMACEUTICAL PREPARATION
EA200000242A1 (en) FANHINONA APPLICATION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
SI1147105T1 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatement of vascular diseases
RS49520B (en) Antimicrobially active mixtures
BR9707770C1 (en) Tifluzamide with improved efficacy
UA30143C2 (en) TREATMENT FOR PREVENTION AND TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES
ATE110714T1 (en) HYDROXAMIC ACID DERIVATIVES WHICH INHIBIT LIPOXYGENASE.
ATE131729T1 (en) 3,5-DIIOD-L-THYRONINE FOR TSH SUPPRESSION AND TREATMENT OF STRUMA
ATE258229T1 (en) SUBSTANCE FA-70D, PRODUCTION METHODS AND USES
PT986390E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CYCONHONINE CYCLORIDRATE
BR9710629A (en) Pharmaceutical composition Process for its preparation Compound for use as a therapeutic agent and use and use of a compound
IT1216096B (en) L_PIROGLUTAMIL_L_CISTEINA, DIPEPTIDE WITH HIGH ANTI-CATHATOGEN ACTIVITY AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
KR930019216A (en) Tumor treatment
EA200101157A1 (en) 14β-H-STEROLS CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS AND THE APPLICATION OF THESE DERIVATIVES FOR THE PREPARATION OF MEDICINES OF REGULATING MEIOSE
HU9802896D0 (en) Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
DE69833317D1 (en) CONAGENINE FOR THE TREATMENT OF ULTRA-TERM COLITIS AND / OR MORBON CROHN
MX9605633A (en) Pharmaceutical composition for preventing or treating dry eye or disease caused therefrom.